StockGlow

Enveric Biosciences, Inc. (ENVB)

Develops psychiatric drugs based on psychedelic compounds like DMT and mescaline.

$1.32-0.01%Healthcare
Compare ENVB with
StockGlow Score
3
Bearish
BearishBullish
1 year ago-90.4%

The outlook

ENVB trades at $1.32, near its 52-week low with minimal analyst coverage available. The stock sits below both its 50- and 200-day moving averages, reflecting a downtrend. Current data shows weak technical positioning overall.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range0% of the way from its 52-week low to high
Market cap
$5.3M
52-wk high
$17.64
52-wk low
$1.25
50-day avg
$1.65
200-day avg
$3.57
Trailing P/E
—

Similar stocks

ADTXAditxt, Inc.$0.00-6.25%ENSCEnsysce Biosciences, Inc.$0.25-4.24%PALIPalisade Bio, Inc.$2.03-0.25%RKTORocket One Inc.$0.78+1.06%PHIOPhio Pharmaceuticals Corp.$1.02-3.33%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy